Skip to main content

TNBC Foundation Virtual 5K

Tue October 1 - Thu October 31
Fundraiser

Cherie Hudson
Together we fight!

Fundraiser Login
Donate

$20

Raised of $500

$0
$500

Story

May 18, 2022 marked the beginning of my Breast Cancer journey. After noticing a small, almost unnoticeable, lump in my left breast following a self exam and then a mammogram, I was diagnosed with Stage 1B, Grade 3 Triple Negative Breast Cancer.

 

Today, I am a proud survivor and thriver. I am celebrating 1 year and 3 months of survivorship after 5 months of IV chemotherapy, a lumpectomy, 14 rounds of radiation, and 4 months of oral chemotherapy. Cancer doesn't discriminate, and it gives no choice. But it has given me a different perspective on what matters. I am a mom of 2 precious, young children. I have been married for 9 years to the love of my life and best friend. I am thankful to be alive and to be able to enjoy each day with the ones I love!

 

TNBC accounts for approximately 15 percent of invasive breast cancers. It is an aggressive type of tumor with a faster growth rate, higher risk of metastasis and recurrence risk. 

 

Breast cancer subtypes are determined by the presence or absence of hormone receptors (estrogen, progesterone, her2). TNBC lacks all three. It is an aggressive type of tumor with a faster growth rate, higher risk of metastasis and recurrence risk. Treatment may be less available now, but join me in raising funds to help progress research for TNBC.

 

I will be participating in a virtual 5K at the end of October to support the Triple Negative Breast Cancer Foundation, an organization I care deeply about.

 

Please support me by making a donation to help me reach my fundraising goal!

Recognitions

$100
$500
$1,000

Top Donors

$20 Raised By 1 Donor

$20 from Anonymous

If you continue to use this site, you consent to use all cookies. We use cookies to offer you a better browsing experience. Read how we use cookies and how you can control them by visiting our Privacy Policy.

If you continue to use this site, you consent to use all cookies.